Possession penalty
Possession is a felony; for less than 1 gram, the stated first-offense range is 1–3 years in prison. Higher quantities carry different ranges.
GA Psilocybin law · Reviewed Nov 12, 2026
Psilocybin mushrooms remain illegal in Georgia for personal possession, cultivation, and sale.
Possession is a felony; for less than 1 gram, the stated first-offense range is 1–3 years in prison. Higher quantities carry different ranges.
No established state psilocybin treatment program is described. HB 717, signed May 12, 2026, provides for regulation and licensing of psychedelic-assisted-treatment clinics; rules are due by December 31, 2026, and clinic compliance begins July 1, 2027. HB 382’s carveout applies only if a crystalline-polymorph psilocybin drug receives FDA approval and DEA scheduling. A veterans-and-first-responders research pilot (HB 1296) died; no enacted psilocybin trial-funding program is stated.
No city or county measures found in our sources.
Georgia’s dangerous-drug schedule lists mushroom spores that, when mature, contain psilocybin or psilocin; possession, sale, or transfer may be restricted.
Our sources did not address amanita for Georgia. It is not federally controlled; check state food and drug rules.
HB 382 also provides a conditional exclusion for an FDA-approved lysergide-tartrate drug subject to DEA scheduling. SB 631, proposing grants for FDA-approved ibogaine trials for veterans, died. MDMA is not addressed in the sources.
Georgia has a law that would let doctors prescribe an FDA-approved psilocybin medicine once federal approval and rescheduling happen. It does not legalize mushrooms.
Atlanta introduced a resolution to deprioritize enforcement; it stalled in committee.
May 11: HB 382 was signed. Its exclusion for qualifying FDA-approved crystalline-polymorph psilocybin drugs is conditional on FDA approval and DEA scheduling.
May 12: HB 717 was signed, providing for regulation and licensing of psychedelic-assisted-treatment clinics.
HB 1296 and SB 631, which proposed a veterans-and-first-responders research pilot and ibogaine trial grants respectively, died during the session.
December 31: HB 717's medical-board rules deadline.
July 1: HB 717 clinic compliance date.
Number of states in each category. Georgia’s category is highlighted.
Access score from 0 (illegal) to 5 (licensed adult access).
Listings describe themselves; Pscilly does not sell psilocybin, and sellers outside a state program are labeled “not state-licensed.”
Psilocybin mushrooms remain illegal in Georgia for personal possession, cultivation, and sale.
Possession is a felony; for less than 1 gram, the stated first-offense range is 1–3 years in prison. Higher quantities carry different ranges.
No established state psilocybin treatment program is described. HB 717, signed May 12, 2026, provides for regulation and licensing of psychedelic-assisted-treatment clinics; rules are due by December 31, 2026, and clinic compliance begins July 1, 2027. HB 382’s carveout applies only if a crystalline-polymorph psilocybin drug receives FDA approval and DEA scheduling. A veterans-and-first-responders research pilot (HB 1296) died; no enacted psilocybin trial-funding program is stated.
Georgia’s dangerous-drug schedule lists mushroom spores that, when mature, contain psilocybin or psilocin; possession, sale, or transfer may be restricted.
Pscilly classifies Georgia as: illegal, reform underway. Laws change often, so check the linked sources and current state rules.
Educational summary, not legal advice. Pscilly reviewed these laws on November 12, 2026 using the sources listed; laws change often, so confirm current rules with the state or a lawyer. Psilocybin remains a Schedule I controlled substance under federal law.
Pscilly is a mushroom directory and marketplace for the U.S., Canada, Europe and beyond, covering mushroom shops, licensed psilocybin centers, smart shops, retreats, mushroom brands, delivery services, events and deals. Listings come from the businesses themselves and from public sources, and every listing links to the business.